Revenue | ₹57.89Cr |
Net Profits | ₹5.96Cr |
Net Profit Margins | 10.30% |
Kilitch Drugs (India) Ltd’s revenue jumped 66.59% since last year same period to ₹57.89Cr in the Q3 2024-2025. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated 9.97% jump in its revenue since last 3-months.
Kilitch Drugs (India) Ltd’s net profit jumped 104.81% since last year same period to ₹5.96Cr in the Q3 2024-2025. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -30.86% fall in its net profits since last 3-months.
Kilitch Drugs (India) Ltd’s net profit margin jumped 22.94% since last year same period to 10.30% in the Q3 2024-2025. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -37.13% fall in its net profit margins since last 3-months.
The revenue for Kilitch Drugs (India) Ltd in the Q3 results 2024 was ₹57.89Cr.
The net profit for Kilitch Drugs (India) Ltd in the Q3 results 2024 was ₹5.96Cr.
The net profit margin for Kilitch Drugs (India) Ltd in the Q3 results 2024 was 10.30%.
The revenue for Kilitch Drugs (India) Ltd in the Q3 results 2023 was ₹34.75Cr.
The net profit for Kilitch Drugs (India) Ltd in the Q3 results 2023 was ₹2.91Cr.
The net profit margin for Kilitch Drugs (India) Ltd in the Q3 results 2023 was 8.37%.